Global Next-Generation Sequencing (NGS) Market 2018 Top Vendors are Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, BGI, Oxford Nanopore Technologies Ltd, PerkinElmer, Inc., GATC, Agilent Technologies, Roche, Macrogen Inc, Eurofins

Next Generation Sequencing (NGS) market research report is a proven source of information which offers a telescopic view of the current market trends, situations, opportunities and status. The data and the information regarding the Next Generation Sequencing (NGS) industry are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts. The data and the information regarding the Next Generation Sequencing (NGS) industry are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts. It covers major manufacturers, suppliers, distributors, traders, customers, investors and major types, major applications.

Global Next-Generation Sequencing (NGS) Market accounted to USD 13.51 billion by 2022 growing at a CAGR of 22.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

For A Sample Copy of the Report or Any Further Inquiries @http://databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market

Global Next Generation Sequencing (NGS) Market By Product (Instruments (Hiseq series, Miseq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system), Consumables (Sample preparation consumables, Other), Services (Sequencing services, Data management services), by Application (Diagnostics, Drug Discovery , Biomarker Discovery , Precision Medicine , Agriculture & Animal Research), by End-user (Hospitals & Clinics, Research Centers and Academic & Government Institutes, and Pharmaceutical & Biotechnology Companies), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Major Market Drivers and Restraints:

• Advanced technology in NGS platforms and increased applications of NGS.

• Increased in adoption of NGS among research laboratories and academic institutes.

• Efficient speed, cost, and accuracy of the technology.

• Drug discovery applications in NGS technology are some of the factors which drives the market.

• R&D investments are another factor to grow the market.

• Lack of skilled technicians.

• Accuracy and uniformity concerns in diagnostics testing limits the growth of market.

• Interpretation of complex data and issues regarding storage of sequencing data hinders the market.

• Legal and ethical issues are the challenge in the growing market.

• Emerging markets are proving the new opportunities in the growth of the market.

• Application of NGS in precision medicines & Biomarker discovery.

The Global Next-Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors:

• Illumina, Inc.,
• Thermo Fisher Scientific Inc.,
• Pacific Biosciences of California, Inc.,
• QIAGEN,
• BGI,
• Oxford Nanopore Technologies,
• PerkinElmer, Inc.,
• GATC Biotech AG,
• Agilent Technologies,
• F. Hoffmann-La Roche Ltd,
• Macrogen, Inc.,
• Eurofins Scientific,
• Biomatters Limited,
• Genomatix GmbH,
• PierianDx, Myriad Genetics, Inc.,
• Partek Incorporated,
• DNASTAR, Inc.,
• New England Biolabs
• Among others.

Reasons to Purchase this Report

· Current and future of Global Next Generation Sequencing (NGS) Market outlook in the developed and emerging markets

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

· Regions/countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report

· The report includes the complete segmentation displayed above across all above mentioned countries

Short Table of Contents (TOC)

1. INTRODUCTION
1.1 OVERVIEW OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET
1.2 CURRENCY AND PRICING
1.3 LIMITATION
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE
2.3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET:
RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 BY PRODUCT
6.1 OVERVIEW
6.2 INSTRUMENTS
6.3 CONSUMABLES
6.4 SERVICES
7 BY APPLICATION
7.1 OVERVIEW
7.2 DIAGNOSTICS
7.3 DRUG DISCOVERY
7.4 BIOMARKER DISCOVERY
7.5 PRECISION MEDICINE
7.6 AGRICULTURE & ANIMAL RESEARCH
8 BY END-USER
8.1 OVERVIEW
8.2 HOSPITALS & CLINICS
8.3 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9 BY GEOGRAPHY
9.1 COUNTRYWISE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10 COMPETITIVE LANDSCAPE
10.1. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET:
COMPANY SHARE ANALYSIS
10.2. NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET:
COMPANY SHARE ANALYSIS
10.4. APAC NEXT GENERATION SEQUENCING (NGS) MARKET:

11 COMPANY PROFILES
11.1 QIAGEN
11.2 BGI
11.3 OXFORD NANOPORE TECHNOLOGIES
11.4 F. HOFFMANN-LA ROCHE LTD
11.5 PERKINELMER INC.
11.6 GATC BIOTECH AG
12 APPENDIX
13 ABOUT DATA BRIDGE MARKET RESEARCH

Key Benefits

• The study provides an in-depth analysis of the Next Generation Sequencing (NGS) market size along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the predominant Next Generation Sequencing (NGS) market opportunities.

• A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Next Generation Sequencing (NGS) market.

To Inquire before Buy Complete Report Click here@ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-next-generation-sequencing-ngs-market

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.